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Abstract
The COVID-19 pandemic continues to pose a global threat. As of March 31, 2020, there were 1,528 confirmed COVID-19 cases with 136 deaths in Indonesia. 
This study aimed to describe the epidemiological features and clinical course of COVID-19 in Situbondo District, East Java Province, Indonesia, to facilitate 
understanding of the epidemiological situation and the spread of infection in the community to improve the control and prevention measures. This study 
examined the epidemiological features of COVID-19 cases in Situbondo using descriptive analysis. The results revealed that from March to November 
2020, there were 1,622 suspected cases and 816 confirmed cases. Moreover, females (total case 470%) were more likely to be infected than males (total 
case 346%). Mainly, the cases of COVID-19 infection were in the age group of 19-37 years old (36.8%), and almost half of the confirmed cases (41 
cases) were caused by the infection from close contact to confirmed cases, based on the epidemiological investigation report. People with comorbidities 
were more susceptible to being infected. Hypertension (8.7%), diabetes (8.6%), heart disease (3.7%), kidney failure, and COPD, each by (1%) were the 
highest reported comorbidities in COVID-19 patients. There was another disease with a low percentage like asthma, pulmonary TB, and cancer. 
This study opens the gate to further studies, which are needed to understand more about the epidemiological COVID-19 situation in the community. 
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Introduction
The novel coronavirus disease is caused by the severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-
2). The COVID-19 pandemic continues to pose a global 
threat. Despite extensive research efforts worldwide, sci-
entists have yet to develop either an effective vaccine or 
viable treatment options.1 As of March 31, 2020, there 
were 1,528 confirmed COVID-19 cases with 136 deaths 
in Indonesia.2
After the emergence of many cases of respiratory in-
fection in Wuhan, Hubei Province, China, in December 
2019, coronavirus was identified as the primary cause 
behind the disease and death cases; as of January 31, 
2020, this pandemic has spread to 19 countries, where 
the number of confirmed cases was about 11,791 includ-
ing 213 deaths. The World Health Organization (WHO) 
declared this pandemic a Public Health Emergency of 
International Concern (PHEIC).3
Coronaviruses are members of the Coronaviridae
(Coronavirinae) virus family, infecting a wide range of
hosts and can spread through direct or intermediate
hosts, including avians and bats bovines, camels, canines,
civets, felines, murines, and porcine. Bats have been pro-
posed as natural reservoirs for SARS-CoV and most
coronaviruses.4 The symptoms of infection also ranging
from the common cold to severe and ultimately fatal in-
fections such as SARS, MERS, and, most recently,
COVID-19. SARS-CoV-2 is one of seven human-infect-
ing members of the Coronavirus family; the International
Committee on Virus Taxonomy (ICTV) has named this
virus as severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2).5 The transmission of COVID-19 from
one person to another can be where aerosols can pene-
trate the human body, for instance, through the lungs by
inhalation through the nose or mouth, which occurs due
to close contact with an infected person or exposure to
coughing, sneezing respiratory droplets, or aerosols.6
Moreover, the transmission of droplets (a diameter of >
5-10 µm) may also occur through evaporation in the nat-
ural environment, where the indirect transmission can
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occur through surfaces in the immediate environment or 
other items used by an infected person.7
COVID-19 infection symptoms usually occur after a 
period of around 5.2 days of incubation.8 The average 
number of days from infection to symptom onset is ap-
proximately 14 days. In addition, the time between the 
beginning of COVID-19 symptoms and death varies be-
tween 6 and 41 days. The efficacy of the human body’s 
immune system and age dictate this interval; it is shorter 
in older age groups (70 years old).9 The most common 
symptoms of COVID-19 infection are fever, cough, and 
tiredness, while other signs and symptoms include spu-
tum production, nausea, and vomiting. Symptoms of lym-
phopenia include headache, hemoptysis, diarrhea, dysp-
nea, and lymphopenia.10,11 In addition, according to the 
findings of another study, fever and cough were the most 
common COVID-19 symptoms, and they were accompa-
nied by myalgia, tiredness, dyspnea, and anorexia.12
Individuals infected with COVID-19 rarely had intes-
tinal signs and symptoms (e.g., diarrhea); around 20% to 
25% of patients infected with SARS-CoV and MERS-
SARS suffered from diarrhea.12 According to the find-
ings of research conducted in Mainland China, hyperten-
sion and diabetes were the most-often reported comor-
bidities in patients with COVID-19 infection, along with 
COPD and malignancies.13 Other studies reveal that obe-
sity also is one of the common comorbidity in COVID-19 
patients.14 The goal of this study was to characterize the 
epidemiological characteristics and clinical course of 
COVID-19 in Situbondo District to better understand 
the epidemiological situation and the transmission of 
infection in the community and improve control and 
preventative efforts.
During epidemic week 47, November 2020, there had 
been an increase in the confirmed cases of COVID-19 in 
Indonesia. Also, there was an increase of confirmed cases 
(29,419) which were higher (17.8%) compared to the 
rise in cases epidemic week 46 (24,995). Twenty-two 
provinces experienced an increase in confirmed cases, 
while only 12 provinces experienced a decrease in cases. 
East Java is still in the second position with the highest 
number of positive confirmed cases in Indonesia 
(November 2020). It has a total of 55,286 cases and is 
still in the first position concerning the highest number 
of cumulative deaths with a CFR of 7.15%.16
Situbondo District is one of the regions in East Java 
Province. This area is located in the northern part of East 
Java, with a total population of about 685,776. The re-
gion is significant in terms of intense economical activity 
and geographical location, as it is located on the Java-Bali 
road route, leading to the island of Bali, and has faced an 
unrelenting rise in the incidence of COVID-19 infection 
and death. These factors made it critical for the authors 
to conduct this study in this district. The total of suspect-
ed cases was 1,622 (from March-November 2020).The 
confirmed cases were 816 via the laboratory confirma-
tion testing using the rapid test and SWAB analysis for 
all the confirmed cases. In addition, the growing of con-
firmed positive cases suggested that the epidemic has 
continued to spread in the community, which culminates 
in a more significant burden on the health system to deal 
with the epidemic.
Method
A descriptive Epidemiology study was utilized, and 
the study results were interpreted using percentages, 
numbers, and graphs. The data of COVID-19 were col-
lected from The Epidemiological Surveillance system in 
the Situbondo District. Data from March 28 to November 
16, 2020, were extracted in this study. The positive cases of 
COVID-19 were confirmed according to the results of a 
quantitative Reverse Transcription-Polymerase Chain 
Reaction (qRT-PCR) assay of throat or inside the nose 
swab specimens of those identified as confirmed cases of 
COVID-19. All the cases with incomplete information 
were excluded. Data were analyzed using (SPSS) Statistics 
(25.0) Excel program and presented using tables, 
graphs, and charts for analysis, display, and 
interpretation.
Results 
From March to November 2020, the number of sus-
pected cases was 1,622, and confirmed cases were 816. 
Females were more likely to be infected with COVID-19 
than males, with a total confirmed case of females was 
470 (58 %), and the male was 346 (43%) (Table 1). The 
most significant number of positive confirmed cases, 
with 36.8%, were in the age range of 19-37 years old. 
The second-largest percentage was from the age group of 
38-56 years old (32.5%). It was followed by the age
group of 57-75 years old (18.9%), 0-18 years old
(9.4%), and 76-94 years old (1.6%). Some exposure cri-
teria were identified and presented in Table 1 of the con-
firmed positive cases.
There is still debate about whether gender is a predis-
posing factor for COVID-19. Many reports conducted in 
China and other countries stated that the male gender
Table 1. The Sex Ratio and Age Groups for a Confirmed Case of COVID-19 
in Situbondo District on March to November 2020 
Variable       Category    Frequency   Percent (%)        Valid           Cumulative
Percent (%)    Percent (%)
Gender          Male 346 42.4 42.4 42.4
Female 470 57.6 57.6 57.6
Total 816             100.0           100.0
Age Group     0-18 84 10.3 10.3 10.3
19-37 300 36.8 36.8 47.1
38-56 265 32.5 32.5 79.5
57-75 154 18.9 18.9 98.4
76-94 13 1.6 1.6 100.0
Total 816             100.0           100.0
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has more severity and high mortality.16,17 Men’s cases 
tended to be more severe than women’s (p = 0.035), ac-
cording to research by Jin et al. 19 Based on statistics in 
Situbondo, the number of males who died from 
COVID-19 is 2.4 or twice the number of women. The 
SARS-CoV-2 virus targets the cells via an angiotensin-
converting enzyme (ACE2) receptor, where had 
previously been reported that increased ACE2 receptor 
protein expression in distinct organs was associated with 
specific organ failures as evidenced by clinical data in 
SARS patients.18 It has been shown that circulating 
ACE2 levels are higher in men than in women and 
patients with diabetes or cardiovascular diseases.19 
There is still no universal surveillance description for 
recovery in COVID-19 patients; even though they were 
not hospitalized for SARS-CoV-2 infection, many people 
experience long-term symptoms, ill health, and 
diminished functioning.20 Long-haul COVID must 
be transformed from an anecdote into something that 
is regularly quantified and tracked, just as deaths and 
positive tests are now.21
The COVID-19 cases must be counted in addition to 
positive test statistics to make this pass. Healing should 
be described in terms of symptom length, fluctuations, 
severity, quality of life, and functions, rather than relying 
solely on no active SARS-CoV-2 infection or hospital dis-
charge. Thus, the number of people who have been sick 
for a long time must be monitored, not just to provide 
treatment and care but also to redefine the true impact of 
the epidemic and report the appropriate response. This is 
obtained information by knowing the actual number of 
recovered cases from infection SARS-CoV-2. It is critical 
to improving reporting of clinical cases without laborato-
ry confirmation by defining how current programs should 
perform. To assess the actual risk of disease associated 
with SARS-CoV-2 infection, public health agencies must 
also agree on definitions of what constitutes recovery.22 
The findings of the study also indicated that, in 
Situbondo (Figure 1), at least 681 persons recovered 
from all instances of coronavirus infection (84 %), while 
the number of fatalities was 72 (9%).
Transmission of coronavirus infection from asympto-
matic persons is a severe issue in the COVID-19 pan-
demic. This was because individuals with no or mild 
symptoms might be unrecognized and would be a source 
of infection among the community, especially when 
health services are weak or non-existent in some 
places.23 Also, the level of health awareness and the 
economic influence transmission of the virus in the 
community. Some test results may not identify the 
person who carries the virus. Yet, Serologic testing 
for SARS-CoV showed a positive rate of 13% in 
asymptomatic individuals compared to 82% in severe 
disease and 4% with mild symptoms.24 The result 
obtained in Figure 2 showed that the number of 41% 
cases was in close contact with confirmed cases. 
Also, the most significant percentage of disease 
transmission was among those exposed while going to 
their workplaces or by people who interacted with 
them daily, either in the work environment or elsewhere. 
One of the reasons behind a high infection rate in society 
was the failure to follow health protocols in dealing with 
infected cases, especially in terms of home quarantine.
On the other hand, the technique of wearing a mask 
comprised the following eight steps where health stan-
dards must be included in the use of personal protective 
equipment. The use of masks was not just when caring 
for sick people at home, which was essential, but also by 
those who have symptoms and signs of disease: (1) wash 
your hands before putting on the mask; (2) choose the 
correct mask scale; (3) make sure the mask’s colored side 
is facing outward (for colored masks), or the folds are 
facing downward and outward (for folded masks) (for 
uncolored masks); (4) keep in mind that the metal strip 
is on the upper side of the element; (5) ensure that the 
elastic bands or cords are in the right place; (6) press the 
steel strip tightly so that it molds according to the nose 
and face bridge shape; (7) cover the nose, mouth, and 
chin with a face mask; and (8) avoid rubbing the mask 
on the face until it has been covered and wash your hands 
before and after touching the mask. The following four 
procedures should be followed before removing a mask 
properly: (1) before removing the mask, wash your
Figure 1. The COVID-19 Case in the Situbondo Area from March to
November 2020 Figure 2. Identify Exposure Criteria of COVID-19 from March to November 
2020 in Situbondo District
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hands; (2) only the elastic bands can be touched; (3)
place the used mask in a plastic or paper bag or a trash
can with a lid; and (4) after removing the mask, wash
your hands.24
According to the total number of COVID-19 positive
cases in the Situbondo District, some of the deaths were
accompanied by comorbidities such as diabetes, heart
disease, malignant uterine tumor, cancer, asthma, pul-
monary TB, cardiomegaly, hypertension, COPD, and re-
nal failure (Figure 3).
Comorbidity is a medical term used to describe a con-
dition present simultaneously in those with a related med-
ical condition. Comorbidity basically refers to the impact
of any additional conditions, physiological or psycholog-
ical, that a patient may have, and the primary condition
of concern. Combining a long-term illness and a severe
viral infection such as COVID-19 thus presents a difficult
challenge to the medical community in saving lives.25 The
results of this epidemiological study in Situbondo District
showed the features and comorbidity in COVID-19 pa-
tients. The five highest reported comorbidities in the
Situbondo District were hypertension with a percentage
of 8.7%, diabetes (8.6%), heart disease (3.7%), kidney
failure, and COPD, each by 1%. Other diseases with low
prevalence rates included asthma, pulmonary tuberculo-
sis, tumors, and cancer. Diabetes, cardiovascular disease,
and hypertension were the most prevalent chronic co-
morbidities among persons with severe asthma, accord-
ing to research by Barron et al.26
Hypertension is a prevalent condition that affects the 
elderly. This group of persons appears to be at a higher 
risk of contracting the SARS-CoV-2 virus and developing 
severe COVID-19 symptoms and consequences. Older 
age is often associated with weakened immunity, which 
is thought to increase vulnerability to COVID-19 infec-
tion.25 It is yet uncertain if uncontrolled blood pressure 
is a risk factor for COVID-19 infection; nonetheless, even 
if it does not influence susceptibility to the illness, man-
aging blood pressure is an essential concern for reducing 
the disease burden when infected with the SARS-CoV-2 
virus.27 Diabetes was the second most common comor-
bidity in the Situbondo District. The host’s defenses, par-
ticularly granulocyte and macrophage function, are 
known to be harmed by this condition. People with dia-
betes are more susceptible to a variety of dangerous ill-
nesses. Poor glycemic control has been linked to major 
infections and hospitalization and is thought to increase 
the hyperimmune response related to severe COVID-19 
infection.28
Conclusion 
The study results showed that the spread of infection 
within the community is occurring mainly because the 
community is still not disciplined in carrying out social 
distancing and independent isolation. In several public 
places, such as traditional markets, the use of masks is
Figure 3. Comorbidities of COVID-19 from March to November 2020 in Situbondo District
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still not completely obeyed. Additionally, in certain con-
firmed positive cases with mild symptoms, some had not 
carried out independent isolation according to the proto-
col for various reasons, one of which was earning a living 
according to the people’s daily activity. Additionally, peo-
ple with comorbidities such as hypertension and diabetes 
are more susceptible to being infected with COVID 19. 
Thus, early discovery, diagnosis, treatment, and quaran-
tine, as well as limiting secondary infections among close 
contacts, are all necessary steps in preventing COVID-19 
from spreading from person to person.
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